Market Research Logo

Canada Pharmaceuticals & Healthcare Q1 2019

Canada Pharmaceuticals & Healthcare Q1 2019

Key View:

The provision in the United States-Mexico-Canada Agreement extending biologic data protection from eight to ten yearswill increase the cost of medicines in Canada and weigh negatively on the biosimilar industry. This poses upside risks to our marketforecasts, given the increasing impact that biologics are having on pharmaceutical spending. Rising pharmaceutical and healthcarespending combined with the eventual introduction of a universal, single-payer pharmacare system will ensure that pricing pressureand cost control measures remain a government priority.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Americas Innovative Pharmaceuticals Risk/Reward Index
Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Apotex
GlaxoSmithKline
Merck
Novartis
Bausch Health
Canada Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report